Infectious Disease & Vaccines
| 3 min read
A recombinant antivenom made of five nanobodies protected mice against lethal doses of venom from four medically important snake species in India.
| 6 min read
IITGN and JMI researchers identified a molecule targeting a new enzyme, offering a fresh antibiotic strategy against drug-resistant S. aureus
| 3 min read
New results from their Phase 2 trials show promise, but there could be issues moving to Phase 3. GSK's functional cure could be approved in the US before then.
| 3 min read
Scientists showed that a trio of medications successfully cleared the virus in a rhesus macaque infant model. Clinical testing in human infants could move quickly.
| 3 min read
Brown University researchers found genetic variants linked to reduced malaria drug susceptibility, offering a new marker for resistance surveillance.
| 3 min read
A new intravaginal drug delivery platform has been selected to investigate whether localized UTI treatment can reduce the collateral effects of systemic antibiotics.
| 2 min read
A new study showed environmental bacteria can transfer resistance genes to pathogens inside human lungs that were previously sensitive to antibiotics. The findings could prompt new treatments that block the gene transfer.
| 6 min read
Phase Advance is using mechanistic virtual patient models to predict how LEAF4Life's hypoxia-targeting therapy could perform across multiple indications.
| 3 min read
Researchers find that infant airway tissue actively shapes the immune response to RSV, suggesting future therapies should target both the virus and inflammation.
| 5 min read
New population-level data reveal unprecedented declines in cervical cancer among vaccinated cohorts, even as vaccination rates begin to slip in some countries.
| 5 min read
The approach identifies entirely new chemical structures that could help replenish a thinning antibiotic pipeline as resistance continues to rise.
| 3 min read
As a new wave of chronic cough therapeutics enters clinical development, researchers are questioning whether the tools used to measure treatment effects are up to the task.
